Neel Mehta, MD

Articles by Neel Mehta, MD

Future Directions in the Treatment of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 11th 2022

A panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.

Collaboration Among Specialists in the Management of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 11th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss a multidisciplinary approach to treating patients with opioid-induced constipation.

Increasing Awareness Regarding Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 4th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, share their thoughts on how to bring awareness to opioid-induced constipation.

Management of Adverse Effects When Using PAMORAs for Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 4th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss managing adverse events that stem from using peripheral μ-opioid receptor antagonists to treat opioid-induced constipation.

Optimizing Treatment Selection Between Oral and Subcutaneous PAMORAs

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 28th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, consider potential patient preferences when choosing oral vs subcutaneous peripheral μ-opioid receptor antagonists.

Reviewing Different PAMORAs for Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 28th 2022

A multidisciplinary panel shares individual experience with using oral peripherally acting μ-opioid receptor antagonists in managing opioid-induced constipation.

The Role of Mu-Opioid Receptor Agonists in the Management of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 21st 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, review the rationale for the use of μ-opioid receptor agonists for the treatment of opioid-induced constipation.

Transitioning Therapies for Patients With Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 21st 2022

Experts in gastroenterology review the challenges associated with switching therapies during inpatient and outpatient care for patients with opioid-induced constipation.

Selecting Optimal First-Line Treatments for Patients With Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 14th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss the multidisciplinary approaches to selecting therapies for patients with opioid-induced constipation.

Approaches to Care in Patients with Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 14th 2022

A multidisciplinary panel shares practical approaches to treating patients with opioid-induced constipation and challenges with patient communication.

The Role of Specialty Pharmacies in the Management of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 7th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, reviews the position of pharmacies in providing patients with opioid-induced constipation with the necessary medication to decrease hospitalization and cost of medication.

The Impact of Opioid-Induced Constipation on Patient Quality of Life

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 7th 2022

Experts in gastroenterology discuss the quality of life and perspective of patients with opioid-induced constipation.

Education and Identification of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

June 30th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, explore the importance of early intervention and the overall challenges of ensuring that patients receive appropriate care for opioid-induced constipation.